Navigation Links
Positive Results From the MADIT-CRT Trial Support the Expanding Approval of Cardiac Resynchronization Therapy Defibrillators
Date:10/6/2010

0;This makes Boston Scientific the only manufacturer with cardiac resynchronization therapy defibrillator devices approved for all types of NYHA classes of heart failure."

MRG's Global Markets for Cardiac Rhythm Management Devices 2011 report provides critical insight into trends that will fuel and limit market growth for cardiac rhythm management devices in the US, Europe (France, Germany, Italy, and the UK), and Japan. The report includes a breakdown of unit volumes, average selling prices, and market values for pacemakers (single-chamber, dual-chamber, and cardiac resynchronization therapy pacemakers) and implantable defibrillators (single-chamber, dual-chamber, and cardiac resynchronization therapy defibrillators).

About Millennium Research GroupMillennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer behavior tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact:Amy KrohnMillennium Research Group416-364-7776 ext. 101

SOURCE Millennium Research Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ISTA Pharmaceuticals Reports Positive Preliminary Results from its Phase 1/2 Clinical Study of Bepotastine Besilate Nasal Spray for the Treatment of Symptoms Associated with Seasonal Allergic Rhinitis
2. Enobia Reports Positive Results For Phase II Trial of ENB-0040 in Juvenile Hypophosphatasia
3. Dynatronics Announces Positive Year-end Results
4. Intarcia Presents Positive ITCA 650 Phase 2 Study Results for Type 2 Diabetes at EASD
5. ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD)
6. ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmins Potential to Transform the Treatment of Retinal Disorders
7. Bionovo Receives Positive Guidance from FDA on Menerba®
8. OXIS International, Inc. Announces Publication of Positive Results of Ergothioneine Safety Study in the Journal TOXICOLOGY
9. Palatin Technologies, Inc. Announces Positive Safety Results in Subcutaneous Bremelanotide Trial in Men
10. Excaliard Announces Positive Data From Phase 2 Clinical Trial of Its Anti-Scarring Drug, EXC 001
11. Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA Nasal Aerosol in Seasonal Allergic Rhinitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... IRVINE, Calif. , July 30, 2015 /PRNewswire/ ... Novartis /Alcon executives have recently contacted the Company ... will begin as early as Monday, August 3, ... been quoted as saying that the coming electronic ... billions of dollars over the next several years.  ...
(Date:7/30/2015)... PTC Therapeutics, Inc. (NASDAQ: PTCT ) ... for the second quarter ending June 30, 2015. ... the organization.  We are excited to be near the ... ever conducted with topline results expected in the fourth ... PTC Therapeutics, Inc. "Translarna is now commercially available in ...
(Date:7/30/2015)...  Growth of the U.S. nonprescription market is primarily ... users to the OTC market. Due to an increasingly ... switch activity over the next five years with several ... brands entering the market into existing categories. ... (even those with low to moderate likelihood), the market ...
Breaking Medicine Technology:PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3
... June 16 New independent microbiology testing reveals that one in every ... positive for one of three types of pathogens that spread easily and endanger ... , , ... that causes sickness and even death in people with lowered immune systems, were ...
... BRADENTON, Fla. , June 16 Xacore ... Ellis Services and Solutions Enterprises, LLC (ESSE) headed by retired ... his group of experienced professionals to tackle the challenge of ... protection DSP radio headset technology with the strengths of ESSE,s ...
Cached Medicine Technology:Consumers at Risk: One in Six Wood Pallets in Los Angeles Discovered With Potentially Deadly Pathogens 2Consumers at Risk: One in Six Wood Pallets in Los Angeles Discovered With Potentially Deadly Pathogens 3Consumers at Risk: One in Six Wood Pallets in Los Angeles Discovered With Potentially Deadly Pathogens 4Xacore Partners With ESSE, Headed by Retired Army Four Star General, to Tackle Military Hearing Loss 2Xacore Partners With ESSE, Headed by Retired Army Four Star General, to Tackle Military Hearing Loss 3
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... Girl Scouts ... out bullying across Georgia through the Girl Scout "Be a Friend First" program. Representatives ... Thursday, July 30. , “Peach State Health Plan and our parent company, Centene ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... The Mount ... on research projects that evaluate the potential of related, experimental treatments. The collaboration moves ... of Health to award Columbia Care one of five state licenses to produce and ...
(Date:7/31/2015)... ... July 31, 2015 , ... BioViva USA, Inc. (“BioViva”), a to-clinic ... aging diseases. , BioViva announces it has begun a fundraiser through Maximum Life ... (AD) and find a cure. MaxLife will grant 100% of the money raised to ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... the Northern District of Ohio, Western Division (Case No. 3:15-cv-00397) involving the ... the women experienced spontaneous migration of their Implanon® implants, inability to locate the ...
(Date:7/31/2015)... ... July 31, 2015 , ... The Heart Fit Clinic has increased a patient's ... heart rate of 150 beats versus 100 beats, this is a big deal," says ... give life back to patients with heart disease," he adds. People with angina are ...
Breaking Medicine News(10 mins):Health News:Peach State Health Plan Presents $10,000 Check for “Be a Friend First” Anti-Bullying Program to Local Girl Scouts 2Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 2Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 3Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 2Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 3Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 2Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 3Health News:Heart Fit Clinic Helps Patient Increase Fitness Level with External Counterpulsation 2
... measures, study finds , FRIDAY, Aug. 7 (HealthDay News) -- ... cancer have surgery to remove their breasts or ovaries in ... report. , Their study included 211 women, aged 35 to ... to increase the risk of breast and ovarian cancer. The ...
... , , WEST JORDAN, Utah, Aug. ... Jewish Community Center (JCC) the fourth annual Dannon Next Generation Nutrition Grant ... Lake County community. The JCC received $30,000 in support of its ... Fun, Fit & Healthy! will offer weekly, nutritionist-developed ...
... /PRNewswire-FirstCall/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: ... Chairman and Chief Executive Officer, will present at the upcoming ... will take place on Wednesday, August 12, 2009 at 11:00 ... About Transition, ----------------, , ...
... , , , , ... selected Artefill, the first and only FDA-approved microsphere-enhanced collagen filler for ... wrinkles. Kathleen Stegman, RN, M.A. has been an avid Artefill user ... for the long lasting correction of wrinkles. , , ...
... LAUDERDALE, Fla., Aug. 7 Averaging ... critical 24/7 patient information call center, Hospice Partners On Call ... secure colocation facility, to safeguard its powerful server infrastructure and ... Partners On Call decided to move their back-up servers to ...
... , DENVER, Aug. 7 An innovative program ... disease patients and teams of pharmacists, nurses, primary care doctors, and ... two years after they left the program by keeping them in ... by Kaiser Permanente published in The American Journal of Managed Care ...
Cached Medicine News:Health News:Many Opt for Surgery to Lower Breast, Ovarian Cancer Risk 2Health News:The Dannon Company Awards The I.J. & Jeanne Wagner Jewish Community Center the Fourth Annual Dannon Next Generation Nutrition Grant 2Health News:The Dannon Company Awards The I.J. & Jeanne Wagner Jewish Community Center the Fourth Annual Dannon Next Generation Nutrition Grant 3Health News:The Dannon Company Awards The I.J. & Jeanne Wagner Jewish Community Center the Fourth Annual Dannon Next Generation Nutrition Grant 4Health News:Transition Therapeutics to Present at Canaccord Adams 29th Annual Global Growth Conference 2Health News:Midwest Medical Aesthetics Helps Defy Nature and Wrinkles with Artefill 2Health News:Midwest Medical Aesthetics Helps Defy Nature and Wrinkles with Artefill 3Health News:Hospice Partners On Call Selects Category 5 Hurricane Rated 1Vault Networks to Safeguard Server and Call Center Infrastructure 2Health News:Electronic Health Records Help Cardiac Patients Remain Healthy 2Health News:Electronic Health Records Help Cardiac Patients Remain Healthy 3Health News:Electronic Health Records Help Cardiac Patients Remain Healthy 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: